Fresh Tracks Therapeutics, Inc. Stock

Stocks

25-01-27	Fresh Tracks Therapeutics Announces Special Distribution	CI
24-03-15	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-12-21	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI
23-12-18	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	CI
23-11-13	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-09-20	Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	MT
23-09-20	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	MT
23-09-20	Top Premarket Gainers	MT
23-09-19	Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	MT
23-09-19	Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
23-09-19	Fresh Tracks Therapeutics, Inc. Announces Executive Changes	CI
23-08-11	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-07-25	Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	CI

22-11-14	Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	MT
22-09-27	Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	MT
22-08-16	HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	MT
22-05-13	Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	MT
22-05-13	Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	MT

25-02-25	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
25-01-29	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
25-01-27	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
24-12-06	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
24-06-17	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ

23-03-08	MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss
23-03-08	MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent
23-03-08	MÄRKTE USA/Wall Street mit leichter Erholung
23-03-08	MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten
23-03-08	MARKT USA/Wall Street stabilisiert nach Vortagesverlusten

1 day

-0.53%

Manager	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	74	2023-10-01
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	2015-12-31
Aaron Fox-Collis DFI	Director of Finance/CFO	-	2022-05-31

Director	Title	Age	Since
Albert Marchio CHM	Chairman	74	2023-10-01

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/7/24	Exploration Capital LLC	Buy	Company	405,500	6.7885%
5/29/24	Exploration Capital LLC	Buy	Company	10,434	0.1747%
5/21/24	Exploration Capital LLC	Buy	Company	22,889	0.3832%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FRESH TRACKS THERAPEUTICS, INC.	-0.53%	+2.75%	-	-	5.59M
WUXI APPTEC CO., LTD.	+10.00%	+13.39%	+51.99%	+83.45%	56.7B
ARGENX SE	+0.80%	-5.70%	+23.89%	+62.65%	51.97B
BIONTECH SE	-0.71%	-0.59%	-16.48%	-13.69%	23.33B
INSMED INCORPORATED	+0.17%	-5.03%	-11.10%	+349.70%	21.34B
GENMAB A/S	+1.73%	-1.57%	+32.81%	-25.80%	17.44B
PHARMAESSENTIA CORPORATION	+4.29%	+1.67%	+201.24%	+344.48%	14.77B
EXELIXIS, INC.	+1.82%	-0.78%	+52.32%	+176.62%	13.84B
ARROWHEAD PHARMACEUTICALS, INC.	+3.98%	+4.22%	+442.97%	+182.46%	12.12B
MADRIGAL PHARMACEUTICALS, INC.	+6.08%	-5.29%	+63.50%	+162.39%	11.14B
Average	+2.78%	-0.63%	+93.46%	+146.92%	24.74B
Weighted average by Cap.	+3.75%	+0.44%	+62.48%	+117.82%